- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myopic Choroidal Neovascularisation in Singapore
Total 55 results
-
BayerRegeneron PharmaceuticalsCompletedMyopia, PathologicalJapan, Taiwan, Hong Kong, Korea, Republic of, Singapore
-
Singapore National Eye CentreNational University Hospital, Singapore; Tan Tock Seng HospitalActive, not recruitingPolypoidal Choroidal VasculopathySingapore
-
Singapore National Eye CentreRecruitingLong-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)Polypoidal Choroidal VasculopathySingapore
-
Novartis PharmaceuticalsCompletedChoroidal Neovascularization (CNV)Korea, Republic of, Germany, Russian Federation, Turkey, Australia, Hungary, Switzerland, Italy, Lithuania, Denmark, Peru, Spain, Portugal, Canada, France, Latvia, Greece, Slovakia, Czech Republic, Poland, Singapore
-
Novartis PharmaceuticalsCompletedPathological MyopiaGermany, India, Japan, Turkey, Austria, Switzerland, Italy, Lithuania, Hungary, France, Slovakia, United Kingdom, Korea, Republic of, Portugal, Hong Kong, Canada, Singapore, Spain, Latvia, Poland
-
Singapore National Eye CentreCompleted
-
Singapore National Eye CentreBayerCompletedAge Related Macular Degeneration | Polypoidal Choroidal VasculopathySingapore
-
Essilor InternationalActive, not recruitingMyopia | Myopia, ProgressiveSingapore
-
Essilor InternationalActive, not recruiting
-
Menicon Co., Ltd.Active, not recruiting
-
Singapore National Eye CentreNational Medical Research Council (NMRC), SingaporeActive, not recruiting
-
Santen Pharmaceutical Co., Ltd.Completed
-
Singapore Eye Research InstituteCompleted
-
Singapore National Eye CentreSingapore Armed Forces; Defence Medical Environmental Research InstituteCompleted
-
Bausch & Lomb IncorporatedCompleted
-
Singapore National Eye CentreSingapore Eye Research Institute; NeuroVisionCompleted
-
Singapore National Eye CentreCompleted
-
Singapore National Eye CentreNeuroVision; Defence Medical Research Institute, Singapore Armed ForcesCompleted
-
Singapore National Eye CentreSingapore Eye Research InstituteCompletedRefractive Error | MyopiaSingapore
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.; Johnson & Johnson K.K. Medical CompanyCompleted
-
Essilor InternationalActive, not recruiting
-
Singapore National Eye CentreUnknown
-
Singapore National Eye CentreSingapore Eye Research InstituteCompleted
-
Essilor InternationalActive, not recruiting
-
Singapore National Eye CentreHealth Promotion Board, Singapore; NeuroVisionCompleted
-
Essilor InternationalActive, not recruiting
-
Singapore Eye Research InstituteCompleted
-
Singapore National Eye CentreUnknownAstigmatism | Myopia | HypermetropiaSingapore
-
Mateon TherapeuticsCompletedPolypoidal Choroidal VasculopathyUnited States, Hong Kong, Korea, Republic of, Singapore, Taiwan
-
Singapore National Eye CentreCompletedGlaucoma | Myopia | MaculopathySingapore
-
Alcon ResearchCompletedRefractive Error - Myopia Severe | Refractive Error - Myopia SimpleUnited States, Ireland, Singapore
-
NovartisCompletedPolypoidal Choroidal VasculopathyHong Kong, Taiwan, Singapore, Korea, Republic of, Thailand
-
National University, SingaporeCompletedObesity | MyopiaSingapore
-
Visioneering Technologies, IncRecruitingMyopiaUnited States, Canada, Hong Kong, Singapore
-
Hyphens Pharma Pte LtdCompletedAtopic DermatitisSingapore
-
Coopervision, Inc.Visioncare Research Ltd.CompletedMyopiaCanada, Portugal, Singapore, United Kingdom
-
National University of SingaporeMinistry of Education, SingaporeActive, not recruitingHypersensitivity | Eczema | Inflammation; Skin | Eczema, AtopicSingapore
-
Coopervision, Inc.Visioncare Research Ltd.CompletedMyopiaCanada, Portugal, Singapore, United Kingdom
-
Johnson & Johnson Surgical Vision, Inc.RecruitingAstigmatism | MyopiaCroatia, India, Italy, Singapore
-
NAOS Argentina S.A.RecruitingAtopic Dermatitis | Eczema, AtopicArgentina, Singapore
-
Novartis PharmaceuticalsCompletedAge-related Macular Degeneration | Polypoidal Choroidal VasculopathyJapan, Taiwan, Hong Kong, Singapore, Thailand, Korea, Republic of, Malaysia
-
ASLAN PharmaceuticalsCompleted
-
University of SouthamptonNational University Hospital, Singapore; Singapore Institute for Clinical Sciences and other collaboratorsEnrolling by invitationNeurobehavioral Manifestations | Allergy | Microbial Colonization | Growth Disorders | Atopic Dermatitis | Obesity, Childhood | Metabolic Disturbance | Cognition | Lifestyle | Breastfeeding | Nutrition, Healthy | AtopySingapore, United Kingdom, New Zealand
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Belgium, Bulgaria, Estonia, France, Georgia, Germany, Hungary, Italy, Poland, Singapore
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
AbbVieCompletedAtopic DermatitisUnited States, Australia, Canada, Croatia, Czechia, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Malaysia, Netherlands, New Zealand, Norway, Poland, Singapore, Spain, Sweden, Taiwan, Ukraine, United Kingdom
-
Eli Lilly and CompanyDermira, Inc.CompletedAtopic DermatitisUnited States, Canada, Taiwan, Singapore, Germany, Bulgaria, Ukraine, Mexico
-
ASLAN PharmaceuticalsCompletedAtopic DermatitisUnited States, Australia, Singapore, India, Canada, New Zealand, Dominican Republic, Poland
-
AbbVieActive, not recruitingAtopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Czechia, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Portugal, Singapore, Spain, Taiwan, United Kingdom
-
Eli Lilly and CompanyDermira, Inc.Active, not recruitingAtopic DermatitisUnited States, Spain, Canada, France, Korea, Republic of, Taiwan, Australia, Germany, Bulgaria, Estonia, Latvia, Lithuania, Mexico, Poland, Singapore, Ukraine